Humana and Boehringer Ingelheim Pharmaceuticals have published a study showing that non-adherence to chronic obstructive pulmonary disease (COPD) medications is linked to non-adherence to medications for other chronic diseases.

The study titled “Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients” was published in the International Journal of COPD.

Chronic lower respiratory diseases are the third leading cause of death in the U.S. One of the most prevalent diseases in this category is COPD, which affects approximately 24 million adults in the U.S.

Although the long-term decline of lung function in COPD patients cannot be reversed by pharmacotherapy, medications are available to prevent and control symptoms, improve health status, and reduce the occurrence of COPD exacerbations.